A novel neuromodulation technique in the treatment of chronic pain.

1. Male or female ≥ 18 years old;

2. Chronic, intractable pain in the thoracic, lumbar, and/or sacral distributions(s) for at least 6 months;

3. Failed conservative treatments for chronic pain including but not limited to pharmacological therapy, physical therapy, and interventional pain procedures for chronic pain;

4. Minimum baseline pain rating of 60 mm on the VAS;

5. Stable pain medication dosage for at least 30 days;

6. Stable neurologic function in the past 30 days.

1. Female subject of childbearing potential is pregnant/nursing, plans to become pregnant or is unwilling to use approved birth control;

2. Escalating or changing pain condition within the past month as evidenced by investigator examination;

3. Subject is currently involved in medically related litigation;

4. Subject currently has an active implantable device including ICD, pacemaker, spinal cord stimulator or intrathecal drug pump;

5. Subject currently has an active infection;

6. Subject has, in the opinion of the investigator, a medical comorbidity that contraindicates placement of an active medical device;

7. Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the investigator, precludes participation;

8. Imaging (MRI, CT, x-ray) findings within the last 12 months that, in the investigator’s opinion, contraindicates lead placement.